Hypomyelinating Leukodystrophy due to HSPD1 Mutations: A New Patient

Area of Science:

• Neurogenetics
• Mitochondrial Biology
• Rare Diseases

Background:

• Hypomyelinating leukodystrophies (HMLs) are a group of rare genetic disorders affecting myelin development.
• Pelizaeus-Merzbacher disease (PMD) and Pelizaeus-Merzbacher-like disease (PMLD) are well-characterized forms of HML.
• Mutations in over 10 genes are known to cause HMLs, underscoring the genetic heterogeneity of these conditions.

Observation:

• A family was previously identified with a homozygous missense mutation in HSPD1, causing autosomal recessive mitochondrial Hsp60 chaperonopathy (MitCHAP-60) disease.
• This study presents the first reported case of MitCHAP-60 disease since its initial description.
• The patient exhibits severe neurodegenerative symptoms and neuroimaging findings consistent with HML.

Findings:

• The patient carries a homozygous missense mutation in HSPD1, confirming the diagnosis of MitCHAP-60 disease.
• Genetic analysis suggests the patient may belong to the same extended family as the previously reported Israeli family.
• This case reinforces the link between HSPD1 mutations and this severe neurodegenerative phenotype.

Implications:

• MitCHAP-60 disease, caused by HSPD1 mutations, should be considered in the differential diagnosis of HML.
• Understanding the genetic basis of HMLs, including rare forms like MitCHAP-60, is crucial for accurate diagnosis and potential therapeutic strategies.
• Further research into mitochondrial chaperonopathies may reveal new insights into neurodevelopmental disorders.